Few Eyebrows Up

Nov 02, 2018

Some experts have raised concerned about 23andMe's new direct-to-consumer pharmacogenetic tests, Time reports.

The US Food and Drug Administration earlier this week gave 23andMe authorization to sell tests for 33 variants linked to the ability to break down certain drugs, as GenomeWeb has reported.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Another Look

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

Some More Than Others

A new analysis finds some cancers receive more nonprofit dollars than others.

Gene Variant's Possible Role

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

Science Finds Sex-Biased Gene Expression in Mammals, More

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.

Menu

Few Eyebrows Up

To read the full story....

The Scan

Another Look

Some More Than Others

Gene Variant's Possible Role

Science Finds Sex-Biased Gene Expression in Mammals, More

What's Popular?

Myriad Genetics Settles Improper Medicare Billing Complaint for $9.1M

European Patent Office Revokes Second Pacific Biosciences Patent

Bio-Rad, 10x Genomics Claim Single-Cell Patent Fight Victories on Different Fronts

Atos Selected to Build Data Infrastructure for French Sequencing Program

Broad Institute, MilliporeSigma Create CRISPR IP License Framework

Sponsorships